Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/27/2025

Probiotic Use in Gastrointestinal Conditions

Introduction to Probiotics

  • The American Gastroenterological Association makes no recommendation for probiotics in IBS due to insufficient evidence, despite 76 randomized trials testing 44 different strains 1, 4
  • Probiotics demonstrate a favorable safety profile with adverse event rates similar to placebo across multiple trials in immunocompetent adults 3

Safety and Efficacy

  • Probiotics are generally safe for long-term use in healthy adults, including those with IBS or recent antibiotic use, but the evidence supporting their effectiveness is limited and strain-specific 1, 2
  • The overall certainty of evidence for most probiotic applications is rated as Low to Very Low due to heterogeneity in patient populations, probiotic strains tested, study designs, and outcome measures 1, 2, 3

Clinical Recommendations

  • The American Gastroenterological Association conditionally recommends specific probiotic strains during antibiotic therapy to prevent Clostridioides difficile infection, but only in high-risk patients (>15% baseline risk) 2, 6
  • Effective strains include Saccharomyces boulardii (59% risk reduction) 6, and two-strain combination of L. acidophilus CL1285 and L. casei LBC80R (78% risk reduction) 2, 6
  • Probiotics should be started at the beginning of antibiotic therapy and continued throughout the antibiotic course, with consideration of extending 1-2 weeks post-antibiotics 6

Contraindications and Precautions

  • Probiotics are contraindicated in immunocompromised patients due to risk of bacteremia and fungemia 6
  • Exercise caution in critically ill patients, those with severe underlying illness, and postoperative patients 6

Evidence-Based Guidelines

  • The British Society of Gastroenterology recommends using probiotics for up to 12 weeks and discontinuing if no improvement occurs 4
  • Multi-strain combinations appear more effective than single strains when used for 8 weeks or longer, though evidence quality remains low 4
  • The Infectious Diseases Society of America states there are insufficient data to recommend probiotics for primary prevention of C. difficile infection outside clinical trials 6